ARCHIVES

Cooperative Group Consolidation Unlikely To Save Money, NCI’s Doroshow Says

This article is from The Cancer Letter archive.

Vol. 36 No. 34 | September 24, 2010

Download PDF Visit The Full Archive

Related Articles

ASCO Advises KRAS Testing In Patients With Metastatic Colorectal Cancer

January 30, 2009

FDA Advisors Recommend Approval Of Taxol for Node-Positive Breast Cancer

September 24, 1999

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

February 17, 2012

New Grants In Ovarian Cancer Ok’d In Concepts By DCBDC Advisors

March 27, 1992

Research Base Would Be Increased In Guideline Change

November 9, 1990

In Brief: IU Cancer Center To Receive $15 Million for Breast Cancer

January 31, 2014